This company listing is no longer active
74H Stock Overview
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
HEXO Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.63 |
52 Week High | CA$6.02 |
52 Week Low | CA$0.63 |
Beta | 2.13 |
11 Month Change | -52.27% |
3 Month Change | -44.74% |
1 Year Change | -75.57% |
33 Year Change | -98.27% |
5 Year Change | -99.65% |
Change since IPO | -99.03% |
Recent News & Updates
Recent updates
Shareholder Returns
74H | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -8.7% | -1.0% | 0.2% |
1Y | -75.6% | -19.3% | 8.5% |
Return vs Industry: 74H underperformed the German Pharmaceuticals industry which returned -7.4% over the past year.
Return vs Market: 74H underperformed the German Market which returned 4.1% over the past year.
Price Volatility
74H volatility | |
---|---|
74H Average Weekly Movement | 10.9% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 74H's share price has been volatile over the past 3 months.
Volatility Over Time: 74H's weekly volatility has decreased from 18% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | Charlie Bowman | www.hexocorp.com |
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names.
HEXO Corp. Fundamentals Summary
74H fundamental statistics | |
---|---|
Market cap | €27.76m |
Earnings (TTM) | -€189.40m |
Revenue (TTM) | €86.04m |
0.3x
P/S Ratio-0.1x
P/E RatioIs 74H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
74H income statement (TTM) | |
---|---|
Revenue | CA$124.10m |
Cost of Revenue | CA$192.65m |
Gross Profit | -CA$68.55m |
Other Expenses | CA$204.64m |
Earnings | -CA$273.18m |
Last Reported Earnings
Apr 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -6.21 |
Gross Margin | -55.23% |
Net Profit Margin | -220.13% |
Debt/Equity Ratio | 124.7% |
How did 74H perform over the long term?
See historical performance and comparison